Niloy Biswas

Niloy Biswas

Auto-generated profile, based on publicly available information

Niloy Biswas

Department of Software Engineering (SWE) Daffodil International University (DIU) Sukrabad Dhaka 1207 Bangladesh daffodilvarsity.edu.bd

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in BioMed Research International
Verified
Journal Article
Open access
PDF file
NBNiloy Biswas
Niloy Biswas
MAMd Mamun Ali
Md Mamun Ali
ARAbdur Rahaman
Abdur Rahaman
MIMinhajul Islam
Minhajul Islam
MMMd Rajib Mia
Md Rajib Mia
MMMohammad Ali Moni
Mohammad Ali Moni
Almost 17.9 million people are losing their lives due to cardiovascular disease, which is 32% of total death throughout the world. It is a global concern nowadays. However, it is a matter of joy that the mortality rate due to heart disease can be reduced by early treatment, for which early‐stage detection is a crucial issue. This study is aimed at building a potential machine learning model to predict heart disease in early stage employing several feature selection techniques to identify significant features. Three different approaches were applied for feature selection such as chi‐square, ANOVA, and mutual information, and the selected feature subsets were denoted as SF1, SF2, and SF3, respectively. Then, six different machine learning models such as logistic regression (C1), support vector machine (C2), K‐nearest neighbor (C3), random forest (C4), Naive Bayes (C5), and decision tree (C6) were applied to find the most optimistic model along with the best‐fit feature subset. Finally, we found that random forest provided the most optimistic performance for SF3 feature subsets with 94.51% accuracy, 94.87% sensitivity, 94.23% specificity, 94.95 area under ROC curve (AURC), and 0.31 log loss. The performance of the applied model along with selected features indicates that the proposed model is highly potential for clinical use to predict heart disease in the early stages with low cost and less time.